Previous 10 | Next 10 |
DENVER , July 22, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) ("DaVita" or "Company"), today announced preliminary second quarter 2019 financial and operating results and updated guidance for fiscal year 2019. The Company is releasing this information to provide investors w...
DENVER , July 22, 2019 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), a leading provider of kidney care services in the United States and in 9 countries around the world, announced today that it will hold its quarterly conference call to discuss second quarter results on Thursday, Augus...
In a note, UBS says CVS Health's ( CVS -1.4% ) potential entry into home dialysis may have limited success since patients will still need to work with a nephrologist and must belong to a clinic, requirements that CVS may struggle to match through its pharmacy network. More news on: CVS...
DaVita (NYSE: DVA ) and Fresenius Medical Care (NYSE: FMS ) are down 4% and 3% , respectively, premarket, both on light volume, in apparent response to the commencement of a clinical trial evaluating a home dialysis device from CVS Health (NYSE: CVS ) that could pose a comp...
DENVER , July 10, 2019 /PRNewswire/ -- DaVita Kidney Care appreciates President Trump, the Administration and Secretary Azar for taking steps to improve the lives of kidney patients. We appreciate the Administration's willingness to collaborate with the industry to ensure th...
Alder BioPharmaceuticals (NASDAQ: ALDR ) resumed with Neutral rating and $14 (22% upside) price target at Credit Suisse. Shares up 1% premarket. More news on: Alder BioPharmaceuticals, Inc., HMS Holdings Corp., DaVita Inc., Healthcare stocks news, Stocks on the move, , Read more ...
President Trump is scheduled to sign an executive order this morning aimed at shaking up U.S. care for kidney disease, including new incentives to shift dialysis from clinics to the home. Key points : More news on: DaVita Inc., Fresenius Medical Care AG & Co. KGaA, American Renal Asso...
DENVER , July 9, 2019 /PRNewswire/ -- DaVita Kidney Care is energized by the focus from the Administration on kidney health. These government initiatives are expected to support DaVita's investments to further kidney disease prevention, encourage home kidney care and...
Dialysis services providers DaVita (NYSE: DVA ) and Fresenius Medical Care (NYSE: FMS ) are down 1% and 3% , respectively, premarket (both on light volume) on the heels of a report from Politico that the Trump administration is planning to announce initiatives aimed at en...
Would I marry DaVita again? I tend to hold my stocks for a long time, some for many years. This doesn't mean that I buy and forget - quite the contrary: As I usually don't own more than 10-15 stocks, I watch the few eggs in my basket very closely. I check for news, read SEC filings, follow c...
News, Short Squeeze, Breakout and More Instantly...
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call PR Newswire DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, Aug...
2024-06-21 02:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...